Annual EBITDA
-$14.02 M
+$13.83 M+49.65%
June 30, 2024
Summary
- As of February 8, 2025, IBIO annual EBITDA is -$14.02 million, with the most recent change of +$13.83 million (+49.65%) on June 30, 2024.
- During the last 3 years, IBIO annual EBITDA has risen by +$4.32 million (+23.57%).
- IBIO annual EBITDA is now -943.93% below its all-time high of -$1.34 million, reached on June 30, 2007.
Performance
IBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.65 M
-$749.00 K-25.78%
September 30, 2024
Summary
- As of February 8, 2025, IBIO quarterly EBITDA is -$3.65 million, with the most recent change of -$749.00 thousand (-25.78%) on September 30, 2024.
- Over the past year, IBIO quarterly EBITDA has dropped by -$749.00 thousand (-25.78%).
- IBIO quarterly EBITDA is now -369.27% below its all-time high of $1.36 million, reached on June 30, 2021.
Performance
IBIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$12.95 M
+$1.08 M+7.67%
September 30, 2024
Summary
- As of February 8, 2025, IBIO TTM EBITDA is -$12.95 million, with the most recent change of +$1.08 million (+7.67%) on September 30, 2024.
- Over the past year, IBIO TTM EBITDA has increased by +$1.08 million (+7.67%).
- IBIO TTM EBITDA is now -4117.99% below its all-time high of -$306.90 thousand, reached on September 30, 2007.
Performance
IBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IBIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +49.6% | -25.8% | +7.7% |
| 3 y3 years | +23.6% | +38.7% | +60.4% |
| 5 y5 years | -0.5% | +38.7% | +60.4% |
IBIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.6% | -62.3% | +64.3% | at high | +60.4% |
| 5 y | 5-year | -19.5% | +49.6% | -369.3% | +64.3% | -10.3% | +60.4% |
| alltime | all time | -943.9% | +49.6% | -369.3% | +64.3% | -4118.0% | +60.4% |
IBio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.65 M(+25.8%) | -$12.95 M(-7.7%) |
| Jun 2024 | -$14.02 M(-49.7%) | -$2.90 M(+29.1%) | -$14.02 M(-10.8%) |
| Mar 2024 | - | -$2.25 M(-45.6%) | -$15.73 M(-19.1%) |
| Dec 2023 | - | -$4.13 M(-12.6%) | -$19.44 M(-23.9%) |
| Sep 2023 | - | -$4.73 M(+2.6%) | -$25.54 M(-8.3%) |
| Jun 2023 | -$27.85 M(+8.3%) | -$4.61 M(-22.7%) | -$27.85 M(-14.8%) |
| Mar 2023 | - | -$5.96 M(-41.7%) | -$32.67 M(+0.7%) |
| Dec 2022 | - | -$10.23 M(+45.3%) | -$32.46 M(+14.4%) |
| Sep 2022 | - | -$7.04 M(-25.3%) | -$28.39 M(+10.2%) |
| Jun 2022 | -$25.72 M(+40.2%) | -$9.43 M(+64.0%) | -$25.76 M(+72.1%) |
| Mar 2022 | - | -$5.75 M(-6.6%) | -$14.97 M(-4.5%) |
| Dec 2021 | - | -$6.16 M(+39.5%) | -$15.67 M(-4.6%) |
| Sep 2021 | - | -$4.42 M(-425.4%) | -$16.42 M(-10.5%) |
| Jun 2021 | -$18.34 M(+56.3%) | $1.36 M(-121.0%) | -$18.34 M(-16.9%) |
| Mar 2021 | - | -$6.45 M(-6.7%) | -$22.06 M(+15.4%) |
| Dec 2020 | - | -$6.91 M(+9.1%) | -$19.11 M(+29.3%) |
| Sep 2020 | - | -$6.34 M(+168.2%) | -$14.79 M(+26.0%) |
| Jun 2020 | -$11.74 M(-15.9%) | -$2.36 M(-32.6%) | -$11.74 M(-9.5%) |
| Mar 2020 | - | -$3.50 M(+35.4%) | -$12.96 M(+1.4%) |
| Dec 2019 | - | -$2.59 M(-21.3%) | -$12.78 M(-7.1%) |
| Sep 2019 | - | -$3.29 M(-8.4%) | -$13.75 M(-1.4%) |
| Jun 2019 | -$13.95 M(+11.7%) | -$3.59 M(+8.2%) | -$13.95 M(+0.6%) |
| Mar 2019 | - | -$3.32 M(-6.9%) | -$13.87 M(+1.9%) |
| Dec 2018 | - | -$3.56 M(+2.4%) | -$13.61 M(+4.3%) |
| Sep 2018 | - | -$3.48 M(-0.8%) | -$13.04 M(+4.5%) |
| Jun 2018 | -$12.48 M(-0.4%) | -$3.51 M(+14.7%) | -$12.48 M(+0.7%) |
| Mar 2018 | - | -$3.06 M(+2.0%) | -$12.40 M(-3.4%) |
| Dec 2017 | - | -$3.00 M(+2.5%) | -$12.84 M(+0.8%) |
| Sep 2017 | - | -$2.92 M(-14.6%) | -$12.74 M(+1.7%) |
| Jun 2017 | -$12.53 M(+40.7%) | -$3.42 M(-2.2%) | -$12.53 M(+9.5%) |
| Mar 2017 | - | -$3.50 M(+20.9%) | -$11.45 M(+7.4%) |
| Dec 2016 | - | -$2.90 M(+6.6%) | -$10.65 M(+7.5%) |
| Sep 2016 | - | -$2.72 M(+16.4%) | -$9.91 M(+11.2%) |
| Jun 2016 | -$8.91 M | -$2.33 M(-13.8%) | -$8.92 M(+6.0%) |
| Mar 2016 | - | -$2.71 M(+25.8%) | -$8.42 M(+15.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | - | -$2.15 M(+25.2%) | -$7.29 M(+8.6%) |
| Sep 2015 | - | -$1.72 M(-6.1%) | -$6.72 M(+6.2%) |
| Jun 2015 | -$6.30 M(+81.2%) | -$1.83 M(+15.4%) | -$6.32 M(+14.0%) |
| Mar 2015 | - | -$1.59 M(+0.8%) | -$5.55 M(+7.5%) |
| Dec 2014 | - | -$1.57 M(+18.7%) | -$5.16 M(+0.5%) |
| Sep 2014 | - | -$1.33 M(+25.4%) | -$5.13 M(+47.6%) |
| Jun 2014 | -$3.48 M(-39.7%) | -$1.06 M(-12.0%) | -$3.48 M(-3.6%) |
| Mar 2014 | - | -$1.20 M(-22.4%) | -$3.61 M(-11.2%) |
| Dec 2013 | - | -$1.55 M(-572.0%) | -$4.07 M(+16.6%) |
| Sep 2013 | - | $328.00 K(-127.6%) | -$3.49 M(-39.5%) |
| Jun 2013 | -$5.77 M(+9.2%) | -$1.19 M(-28.2%) | -$5.77 M(-1.2%) |
| Mar 2013 | - | -$1.66 M(+70.8%) | -$5.84 M(-18.7%) |
| Dec 2012 | - | -$970.00 K(-50.4%) | -$7.18 M(-6.9%) |
| Sep 2012 | - | -$1.95 M(+55.4%) | -$7.71 M(-3.6%) |
| Jun 2012 | -$5.28 M(-43.1%) | -$1.26 M(-58.1%) | -$8.00 M(+38.5%) |
| Mar 2012 | - | -$3.00 M(+99.9%) | -$5.78 M(+1.2%) |
| Dec 2011 | - | -$1.50 M(-33.2%) | -$5.71 M(-35.2%) |
| Sep 2011 | - | -$2.25 M(-332.6%) | -$8.81 M(-5.0%) |
| Jun 2011 | -$9.28 M(+118.1%) | $965.10 K(-133.0%) | -$9.28 M(-21.5%) |
| Mar 2011 | - | -$2.93 M(-36.4%) | -$11.82 M(+13.7%) |
| Dec 2010 | - | -$4.60 M(+69.7%) | -$10.40 M(+72.8%) |
| Sep 2010 | - | -$2.71 M(+71.9%) | -$6.02 M(+26.1%) |
| Jun 2010 | -$4.25 M(+162.2%) | -$1.58 M(+4.7%) | -$4.77 M(+33.5%) |
| Mar 2010 | - | -$1.51 M(+575.5%) | -$3.58 M(+53.9%) |
| Dec 2009 | - | -$223.00 K(-84.8%) | -$2.32 M(-10.7%) |
| Sep 2009 | - | -$1.47 M(+285.3%) | -$2.60 M(+60.4%) |
| Jun 2009 | -$1.62 M(+0.1%) | -$380.30 K(+49.3%) | -$1.62 M(-21.4%) |
| Mar 2009 | - | -$254.70 K(-49.2%) | -$2.06 M(-8.5%) |
| Dec 2008 | - | -$501.70 K(+3.4%) | -$2.26 M(+10.0%) |
| Sep 2008 | - | -$485.20 K(-41.0%) | -$2.05 M(+9.5%) |
| Jun 2008 | -$1.62 M(+20.6%) | -$822.90 K(+84.3%) | -$1.87 M(+78.3%) |
| Mar 2008 | - | -$446.40 K(+50.1%) | -$1.05 M(+73.9%) |
| Dec 2007 | - | -$297.50 K(-3.1%) | -$604.40 K(+96.9%) |
| Sep 2007 | - | -$306.90 K | -$306.90 K |
| Jun 2007 | -$1.34 M | - | - |
FAQ
- What is iBio annual EBITDA?
- What is the all time high annual EBITDA for iBio?
- What is iBio annual EBITDA year-on-year change?
- What is iBio quarterly EBITDA?
- What is the all time high quarterly EBITDA for iBio?
- What is iBio quarterly EBITDA year-on-year change?
- What is iBio TTM EBITDA?
- What is the all time high TTM EBITDA for iBio?
- What is iBio TTM EBITDA year-on-year change?
What is iBio annual EBITDA?
The current annual EBITDA of IBIO is -$14.02 M
What is the all time high annual EBITDA for iBio?
iBio all-time high annual EBITDA is -$1.34 M
What is iBio annual EBITDA year-on-year change?
Over the past year, IBIO annual EBITDA has changed by +$13.83 M (+49.65%)
What is iBio quarterly EBITDA?
The current quarterly EBITDA of IBIO is -$3.65 M
What is the all time high quarterly EBITDA for iBio?
iBio all-time high quarterly EBITDA is $1.36 M
What is iBio quarterly EBITDA year-on-year change?
Over the past year, IBIO quarterly EBITDA has changed by -$749.00 K (-25.78%)
What is iBio TTM EBITDA?
The current TTM EBITDA of IBIO is -$12.95 M
What is the all time high TTM EBITDA for iBio?
iBio all-time high TTM EBITDA is -$306.90 K
What is iBio TTM EBITDA year-on-year change?
Over the past year, IBIO TTM EBITDA has changed by +$1.08 M (+7.67%)